Browse the corpus

REFERENCES Mak RH, DeFronzo RA. Glucose and insulin metabolism in uremia. Nephron 1992; 61:377. Adrogué HJ. Glucose homeostasis and the kidney. Kidney Int 1992; 42:1266. Alvestrand, A. Carbohydrate and insulin metabolism in renal failure. Kidney Int 1997; 52(Suppl 62):S48. Rabkin R, Rubenstein AH, Colwell JA. Glomerular filtration and proximal tubular absorption of insulin 125 I. Am J Physiol 1972; 223:1093. Carone FA, Peterson DR. Hydrolysis and transport of small peptides by the proximal tubule. Am J Physiol 1980; 238:F151. Smith D, DeFronzo RA. Insulin resistance in uremia mediated by postbinding defects. Kidney Int 1982; 22:54. Castellino P, Solini A, Luzi L, et al. Glucose and amino acid metabolism in chronic renal failure: effect of insulin and amino acids. Am J Physiol 1992; 262:F168. Alvestrand A, Wahren J, Smith D, DeFronzo RA. Insulin-mediated potassium uptake is normal in uremic and healthy subjects. Am J Physiol 1984; 246:E174. Goecke IA, Bonilla S, Marusic ET, Alvo M. Enhanced insulin sensitivity in extrarenal potassium handling in uremic rats. Kidney Int 1991; 39:39. McCaleb ML, Izzo MS, Lockwood DH. Characterization and partial purification of a factor from uremic human serum that induces insulin resistance. J Clin Invest 1985; 75:391. Mak RH. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 1992; 41:1049. Kautzky-Willer A, Pacini G, Barnas U, et al. Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int 1995; 47:200. Lin SH, Lin YF, Lu KC, et al. Effects of intravenous calcitriol on lipid profiles and glucose tolerance in uraemic patients with secondary hyperparathyroidism. Clin Sci (Lond) 1994; 87:533. Eidemak I, Feldt-Rasmussen B, Kanstrup IL, et al. Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia 1995; 38:565. Fliser D, Pacini G, Engelleiter R, et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998; 53:1343. Goldberg, AP, Geltman, EM, Gavin, JR. Exercise training reduces coronary risk and effectively rehabilitates hemodialysis patients. Nephron 1986; 42:311.

Fliser D, Pacini G, Engelleiter R, et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998; 53:1343. Goldberg, AP, Geltman, EM, Gavin, JR. Exercise training reduces coronary risk and effectively rehabilitates hemodialysis patients. Nephron 1986; 42:311. Borissova AM, Djambazova A, Todorov K, et al. Effect of erythropoietin on the metabolic state and peripheral insulin sensitivity in diabetic patients on haemodialysis. Nephrol Dial Transplant 1993; 8:93. Mak RH. Effect of recombinant human erythropoietin on insulin, amino acid, and lipid metabolism in uremia. J Pediatr 1996; 129:97. Rabkin R, Simon NM, Steiner S, Colwell JA. Effect of renal disease on renal uptake and excretion of insulin in man. N Engl J Med 1970; 282:182. DeFronzo RA, Tobin JD, Rowe JW, Andres R. Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 1978; 62:425. Fadda GZ, Hajjar SM, Perna AF, et al. On the mechanism of impaired insulin secretion in chronic renal failure. J Clin Invest 1991; 87:255. Perna AF, Fadda GZ, Zhou XJ, Massry SG. Mechanisms of impaired insulin secretion after chronic excess of parathyroid hormone. Am J Physiol 1990; 259:F210. Oh HY, Fadda GZ, Smogorzewski M, et al. Abnormal leucine-induced insulin secretion in chronic renal failure. Am J Physiol 1994; 267:F853. Hajjar SM, Fadda GZ, Thanakitcharu P, et al. Reduced activity of Na(+)-K+ ATPase of pancreatic islets in chronic renal failure: role of secondary hyperparathyroidism. J Am Soc Nephrol 1992; 2:1355. Nadkarni M, Berns JS, Rudnick MR, Cohen RM. Hypoglycemia with hyperinsulinemia in a chronic hemodialysis patient following parathyroidectomy. Nephron 1992; 60:100. Kokot F, Wiecek A, Grzeszczak W, et al. Influence of erythropoietin treatment on glucose tolerance, insulin, glucagon, gastrin and pancreatic polypeptide secretion in haemodialyzed patients with end-stage renal failure. Contrib Nephrol 1990; 87:42. Chagnac A, Weinstein T, Zevin D, et al. Effects of erythropoietin on glucose tolerance in hemodialysis patients. Clin Nephrol 1994; 42:398. Hong SY, Yang DH. Insulin levels and fibrinolytic activity in patients with end-stage renal disease. Nephron 1994; 68:329.

Kokot F, Wiecek A, Grzeszczak W, et al. Influence of erythropoietin treatment on glucose tolerance, insulin, glucagon, gastrin and pancreatic polypeptide secretion in haemodialyzed patients with end-stage renal failure. Contrib Nephrol 1990; 87:42. Chagnac A, Weinstein T, Zevin D, et al. Effects of erythropoietin on glucose tolerance in hemodialysis patients. Clin Nephrol 1994; 42:398. Hong SY, Yang DH. Insulin levels and fibrinolytic activity in patients with end-stage renal disease. Nephron 1994; 68:329. RUNYAN JW Jr, HURWITZ D, ROBBINS SL. Effect of Kimmelstiel-Wilson syndrome on insulin requirements in diabetes. N Engl J Med 1955; 252:388. Weinrauch LA, Healy RW, Leland OS Jr, et al. Decreased insulin requirement in acute renal failure in diabetic nephropathy. Arch Intern Med 1978; 138:399. Peitzman SJ, Agarwal BN. Spontaneous hypoglycemia in end-stage renal failure. Nephron 1977; 19:131. Arem R. Hypoglycemia associated with renal failure. Endocrinol Metab Clin North Am 1989; 18:103. Moen MF, Zhan M, Hsu VD, et al. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol 2009; 4:1121. Topic 1974 Version 4.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0505-61.234.146.186-A1721555EE-S244013.14]